oasis 3 semaglutide Clinical Pharmacy Tuesday is here with a new journal club thanks to @highpoweredmedicine!, The OASIS-4 trial evaluated oral 25 mg for weight loss in adults with overweight or obesity Oral semaglutide 50 mg taken

Tirzepatide and Dual-Compound GLP-Squared as Next-Step Alternatives If semaglutide alone is no longer producing the appetite suppression or weight loss you need, tirzepatide (a dual GIP/GLP-1 receptor agonist) activates two distinct metabolic pathways instead of one

If you suspect an adverse reaction to a berberine patch, report it to the MHRA through the Yellow Card Scheme (yellowcard

There is also a risk low but there for anaphylaxis, a life-threatening allergic reaction that can occur when taking any medication or supplement

Tranexamic Acid (TXA) 40,000ppm targets stubborn hyperpigmentation and post-acne marks at the source